Summit downgraded at H.C. Wainwright after Merck data for sac-TMT
Summit Therapeutics Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $17.54
+4.8% in 3d after detection
Post-detection moves
1h
+2.8%
1d
+0.6%
3d
+4.8%
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS